Healthcare provider profile · identity verified

Content Taylor, NURSE PRACTITIONER

Nurse Practitioner · DETROIT, MI · NPI 1841629466

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1128	348
Albuterol Sulfate Hfa	Albuterol Sulfate	594	188
Amlodipine Besylate	Amlodipine Besylate	571	185
Losartan Potassium	Losartan Potassium	345	104
Lisinopril	Lisinopril	327	95
Famotidine	Famotidine	265	84
Fluticasone Propionate	Fluticasone Propionate	226	81
Metformin Hcl	Metformin Hcl	222	78
Omeprazole	Omeprazole	206	67
Hydrochlorothiazide	Hydrochlorothiazide	204	64
Nifedipine Er	Nifedipine	188	54
Gabapentin	Gabapentin	178	53
Pantoprazole Sodium	Pantoprazole Sodium	178	59
Carvedilol	Carvedilol	170	51
Metoprolol Succinate	Metoprolol Succinate	169	49
Allopurinol	Allopurinol	145	38
Simvastatin	Simvastatin	145	37
Tamsulosin Hcl	Tamsulosin Hcl	131	44
Furosemide	Furosemide	120	46
Clopidogrel	Clopidogrel Bisulfate	119	32
Potassium Chloride	Potassium Chloride	113	38
Metoprolol Tartrate	Metoprolol Tartrate	106	32
Rosuvastatin Calcium	Rosuvastatin Calcium	105	29
Diclofenac Sodium	Diclofenac Sodium	95	39
Ozempic	Semaglutide	95	20
Eliquis	Apixaban	93	29
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	88	27
Levothyroxine Sodium	Levothyroxine Sodium	88	22
Hydralazine Hcl	Hydralazine Hcl	86	26
Triamcinolone Acetonide	Triamcinolone Acetonide	86	36
Trazodone Hcl	Trazodone Hcl	82	26
Isosorbide Mononitrate Er	Isosorbide Mononitrate	76	20
Jardiance	Empagliflozin	75	26
Sertraline Hcl	Sertraline Hcl	72	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	68	16
Ammonium Lactate	Ammonium Lactate	59	21
Breo Ellipta	Fluticasone/Vilanterol	55	21
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	54	12
Vitamin D2	Ergocalciferol (Vitamin D2)	52	20
Levetiracetam	Levetiracetam	48	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	47	16
Spironolactone	Spironolactone	47	18
Atenolol	Atenolol	44	12
Donepezil Hcl	Donepezil Hcl	44	15
Tradjenta	Linagliptin	44	suppressed
Glipizide	Glipizide	43	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	13
Ventolin Hfa	Albuterol Sulfate	41	17
Pravastatin Sodium	Pravastatin Sodium	40	14
Alendronate Sodium	Alendronate Sodium	39	12
Baclofen	Baclofen	39	suppressed
Glipizide Er	Glipizide	39	suppressed
Ezetimibe	Ezetimibe	38	11
Alcohol Prep Pads	Alcohol Antiseptic Pads	35	16
Methocarbamol	Methocarbamol	35	20
Montelukast Sodium	Montelukast Sodium	35	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	35	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	33	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	33	11
Azithromycin	Azithromycin	32	28
Incruse Ellipta	Umeclidinium Bromide	32	suppressed
Prednisone	Prednisone	31	27
Symbicort	Budesonide/Formoterol Fumarate	31	15
Bumetanide	Bumetanide	27	suppressed
Lovastatin	Lovastatin	27	suppressed
Meclizine Hcl	Meclizine Hcl	27	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	27	12
Januvia	Sitagliptin Phosphate	25	suppressed
Nystatin	Nystatin	25	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	25	suppressed
Pregabalin	Pregabalin	25	suppressed
Valsartan	Valsartan	25	suppressed
Alprazolam	Alprazolam	24	suppressed
Entresto	Sacubitril/Valsartan	23	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Novolog Flexpen	Insulin Aspart	22	suppressed
Rybelsus	Semaglutide	22	suppressed
Terazosin Hcl	Terazosin Hcl	22	suppressed
Tramadol Hcl	Tramadol Hcl	22	12
Arnuity Ellipta	Fluticasone Furoate	21	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	21	suppressed
Finasteride	Finasteride	21	suppressed
Lidocaine	Lidocaine	21	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	21	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	20	suppressed
Nitroglycerin	Nitroglycerin	20	suppressed
Tizanidine Hcl	Tizanidine Hcl	20	14
Trulicity	Dulaglutide	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Divalproex Sodium	Divalproex Sodium	19	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	18	suppressed
Ibuprofen	Ibuprofen	18	14
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Desloratadine	Desloratadine	17	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	17	16
Escitalopram Oxalate	Escitalopram Oxalate	17	suppressed
Methylprednisolone	Methylprednisolone	17	15
Ondansetron Odt	Ondansetron	17	16
Spiriva Handihaler	Tiotropium Bromide	17	suppressed
Alcohol Swabs	Alcohol Antiseptic Pads	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Brilinta	Ticagrelor	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Olanzapine	Olanzapine	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	13	suppressed
Torsemide	Torsemide	13	suppressed
Calcitriol	Calcitriol	12	suppressed
Lactulose	Lactulose	12	suppressed
Linzess	Linaclotide	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	11
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Duloxetine Hcl	Duloxetine Hcl	11	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error